NIH-funded research NIH-funded research

Understanding how the immune system protects against tuberculosis

Official title: IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)

Funded at Harvard School of Public Health · NIH-11176666 · Data updated 2026-11-12

This study is looking at how our immune system fights tuberculosis and aims to find ways to improve vaccines for it, especially for people who might also have other infections like HIV. If you're a patient, you might have the chance to help us understand your immune responses to support better vaccine development.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionHarvard School of Public Health
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 30, 2019
Project endSeptember 29, 2025
Funding year2024
Award (this year)$5,537,577
NIH project number75N93019C00071-P00024-9999-1
Project IDNIH-11176666 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include individuals with a history of tuberculosis exposure or those living with HIV, as their immune responses are particularly relevant to the study.

Less likely to help

Patients who are not at risk for tuberculosis or do not have any immune system-related conditions may not benefit from this research.

What this research studies

This research investigates the immune responses necessary for protection against Mycobacterium tuberculosis (Mtb) by analyzing tissue-specific and systemic responses in small animals, non-human primates, and humans. The team aims to identify key immunologic targets that could enhance tuberculosis vaccine strategies. Additionally, the research will explore how infections like HIV and other mycobacteria affect immune responses to tuberculosis. Patients may be involved in studies that assess their immune responses to better inform vaccine development.

Why it matters

Potential benefit: If successful, this research could lead to improved tuberculosis vaccines and better protection for patients against this disease.

How similar studies have gone: Previous research has shown promise in understanding immune responses to tuberculosis, making this approach a continuation of established work in the field.

Where this research is happening

  • Harvard School of Public Health
    Boston, United States
    Active

Researchers

  • Principal investigator: Fortune, Sarah — Harvard School of Public Health
  • Study coordinator: Fortune, Sarah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.